Search hospitals > Ohio > Elyria
Mercy Cancer Center-Elyria
Claim this profileElyria, Ohio 44035
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Cervical Adenocarcinoma
150 reported clinical trials
20 medical researchers
Summary
Mercy Cancer Center-Elyria is a medical facility located in Elyria, Ohio. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Breast cancer, Cervical Adenocarcinoma and other specialties. Mercy Cancer Center-Elyria is involved with conducting 150 clinical trials across 304 conditions. There are 20 research doctors associated with this hospital, such as Shahzad Siddique, Richard T. Lee, David Bajor, M.D., and Jennifer A. Dorth.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Shahzad SiddiquePenrose-Saint Francis Healthcare2 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Breast Cancer
124 reported clinical trials
186 drugs studied
Richard T. LeeCity of Hope Medical Center1 year of reported clinical research
Studies Parotid Gland Cancer
Studies Colon Cancer
12 reported clinical trials
23 drugs studied
David Bajor, M.D.University Hospitals Cleveland Medical Center5 years of reported clinical research
Studies Pancreatic Cancer
Studies Tumors
11 reported clinical trials
22 drugs studied
Jennifer A. DorthCase Western Reserve University7 years of reported clinical research
Studies Parotid Gland Cancer
Studies Squamous Cell Carcinoma
9 reported clinical trials
19 drugs studied
Clinical Trials running at Mercy Cancer Center-Elyria
Breast Cancer
Esophageal Adenocarcinoma
Esophageal Carcinoma
Breast cancer
Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal cancer
Cancer
Parotid Gland Cancer
Ovarian Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mercy Cancer Center-Elyria?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.